Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Congratulations to Dr Bethan Psaila, Dr Benjamin Fairfax, Dr Hashem Koohy, Dr Andrew Blackford and Dr Oliver Bannard who have all been awarded the title of Associate Professor in recognition of their research achievements, contribution to teaching and contributions to the Medical Sciences Division.

We see the photos of five people; one woman and four men. The images are arranged in three boxes on the top row, and two on the bottom row alongside an image of the Institute Logo.

Dr Bethan Psaila is Associate Professor of Haematology

Associate Professor Psaila’s research investigates the use of single-cell methods to understand the development and function of megakaryocytes. Professor Psaila leads the Normal and Malignant Megakaryocyte/Platelet Biology Group and is also a member of the Haematopoietic Stem Cell Biology Group. She is an Honorary Consultant in Haematology at Oxford University Hospitals NHS Trust, and a Senior Fellow of New College, Oxford. Recent research includes investigating the immune response to COVID-19 vaccines in blood cancer patients.

 

Dr Benjamin Fairfax is Associate Professor

Associate Professor Fairfax’s research investigates the genetic and epigenetic factors underlying variation in immune responses. Professor Fairfax leads the Genomics of Inflammation and Cancer Immunology Group. He is an Honorary Consultant Medical Oncologist and the William R. Miller Biomedical Sciences Research Fellow at St. Edmund Hall. Recent research includes evaluation of Immune Checkpoint Blockers (ICBs) in patients with metastatic melanoma.

 

Dr Hashem Koohy is Associate Professor of Systems Immunology

Associate Professor Koohy leads the Machine Learning and Integrative Approaches in Immunology Group in the Human Immunology Group at the WIMM. Professor Koohy’s research incorporates a range of computational, machine-learning and statistical models to understand the recognition of pathogens by T cells. Professor Koohy is also the co-lead for a recent Chan Zuckerberg initiative project. Recent research includes in-silico identification of potential vaccine targets for 2019 novel coronavirus vaccine development.

 

Dr Andrew Blackford is Associate Professor of Molecular Oncology

Associate Professor Blackford’s research studies the signalling mechanisms used by cells to respond to DNA damage, and the relationship between these pathways and diseases such as cancers. Professor Blackford leads the DNA Damage and Disease Group. He is a Cancer Research UK Career Development Fellow and Against Breast Cancer/Oriel College Research Fellow. Recent research includes detailing the molecular mechanisms that control the proposed tumor suppressor, the Bloom syndrome helicase, in cells.

 

Dr Oliver Bannard is Associate Professor

Associate Professor Bannard’s research studies adaptive immune responses. Professor Bannard leads the B Cell Immunology Group. He is a Wellcome Senior Research Fellow. Recent research includes exploring the effect of low iron availability on humoral immunity.

 

Congratulations to all awardees!

Similar stories

Changes in blood cell production over the human lifetime may hold clues to patterns of disease

A new paper published this week in Cell Reports reveals that changes in the gene expression of blood stem cells occur across the human lifetime; an important step in the understanding and treatment of blood disorders.

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

DNA breakthrough could help identify why some people are more affected by Covid-19

Scientists from the MRC Weatherall Institute of Molecular Medicine have developed a method that allows them to see, with far greater accuracy, how DNA forms large scale structures within a cell nucleus.

New clinical trial for patients affected by blood cancer

Radcliffe Department of Medicine's Professor Adam Mead is leading PROMise, a new clinical trial offering a novel treatment option for patients with a type of blood cancer called myelofibrosis.